Free Stock Screener
Load Save Create a watchlist HelpProfit margin
Debt to assets
Cash flow
Balance sheet
(in millions EUR) | 30 Dec 2019 | 29 Sep 2019 | |||
---|---|---|---|---|---|
Current assets | |||||
Cash | €3.217138 | €3.217138 | |||
Short term investments | |||||
Net receivables | €4.435752 | €4.435752 | |||
Inventory | €0.027768 | €0.027768 | |||
Other current assets | €1.15395 | €1.15395 | |||
Total current assets | €8.834608 | €8.834608 | |||
Long term investments | €0.662397 | €0.662397 | |||
Property, plant & equipment | €0.098392 | €0.098392 | |||
Goodwill | |||||
Intangible assets | €1.53799 | €1.53799 | |||
Other assets | €1.717384 | €1.717384 | |||
Deferred long term asset charges | |||||
Total assets | €12.850771 | €12.850771 | |||
Current liabilities | |||||
Accounts payable | €7.191317 | €7.191317 | |||
Short long term debt | |||||
Other current liabilities | €1.847964 | €1.847964 | |||
Total current liabilities | €9.044971 | €9.044971 | |||
Long term debt | €0.006439 | €0.006439 | |||
Other liabilities | €3.799362 | €3.799362 | |||
Deferred long term liabilities | |||||
Minority interest | |||||
Total liabilities | €12.850772 | €12.850772 | |||
Stockholders' equity | |||||
Stock option warrants | |||||
Common stock | €0.653765 | €0.653765 | |||
Retained earnings | -€2.91146 | -€2.91146 | |||
Treasury stock | €2.257694 | €2.257694 | |||
Capital surplus | |||||
Other stockholder equity | €2.257694 | €2.257694 | |||
Total stockholder equity | -€0.000001 | -€0.000001 | |||
Net tangible assets | -€1.537991 | -€1.537991 |
(in millions EUR) | 2019 | 2018 | ||
---|---|---|---|---|
Current assets | ||||
Cash | €3.217138 | €3.873977 | ||
Short term investments | ||||
Net receivables | €4.435752 | €3.681212 | ||
Inventory | €0.027768 | €0.045593 | ||
Other current assets | €1.15395 | €0.340344 | ||
Total current assets | €8.834608 | €7.941126 | ||
Long term investments | €0.662397 | |||
Property, plant & equipment | €0.098392 | €0.150905 | ||
Goodwill | ||||
Intangible assets | €1.53799 | €2.321417 | ||
Other assets | €1.717384 | €0.63556 | ||
Deferred long term asset charges | ||||
Total assets | €12.850771 | €11.049008 | ||
Current liabilities | ||||
Accounts payable | €7.191317 | €5.20364 | ||
Short long term debt | ||||
Other current liabilities | €1.847964 | €1.861317 | ||
Total current liabilities | €9.044971 | €7.071037 | ||
Long term debt | €0.006439 | €0.000067 | ||
Other liabilities | €3.799362 | €2.659643 | ||
Deferred long term liabilities | ||||
Minority interest | ||||
Total liabilities | €12.850772 | €9.730747 | ||
Stockholders' equity | ||||
Stock option warrants | ||||
Common stock | €0.653765 | €0.653765 | ||
Retained earnings | -€2.91146 | -€1.669579 | ||
Treasury stock | €2.257694 | €2.334073 | ||
Capital surplus | ||||
Other stockholder equity | €2.257694 | €2.334073 | ||
Total stockholder equity | -€0.000001 | €1.318259 | ||
Net tangible assets | -€1.537991 | -€1.003158 |
Income statement
(in millions EUR) | 30 Dec 2019 | 29 Sep 2019 | |||
---|---|---|---|---|---|
Revenue | |||||
Total revenue | -€1.176928 | -€1.176928 | |||
Cost of revenue | -€3.045429 | -€3.045429 | |||
Gross profit | €1.868501 | €1.868501 | |||
Operating activities | |||||
Research & development | |||||
Selling, general & administrative | |||||
Non-recurring | |||||
Other operating expenses | €1.857084 | €1.857084 | |||
Total operating expenses | -€2.367024 | -€2.367024 | |||
Operating income | €1.190096 | €1.190096 | |||
Income from continuing operations | |||||
Net other income | -€0.021706 | -€0.021706 | |||
EBIT | €1.190096 | €1.190096 | |||
Interest expense | -€0.002958 | -€0.002958 | |||
Income before tax | €1.16839 | €1.16839 | |||
Income tax expense | -€0.022864 | -€0.022864 | |||
Minority interest | |||||
Net income from continuing ops | €1.191254 | €1.191254 | |||
Non-recurring events | |||||
Discontinued operations | |||||
Extraordinary items | |||||
Effect of accounting change | |||||
Other items | |||||
Net income | |||||
Net income | €1.191254 | €1.191254 | |||
Income (for common shares) | €1.191254 | €1.191254 |
(in millions EUR) | 2019 | 2018 | ||
---|---|---|---|---|
Revenue | ||||
Total revenue | €84.305874 | €86.763298 | ||
Cost of revenue | €79.698283 | €81.961666 | ||
Gross profit | €4.607591 | €4.801632 | ||
Operating activities | ||||
Research & development | ||||
Selling, general & administrative | ||||
Non-recurring | ||||
Other operating expenses | €6.324731 | €4.925399 | ||
Total operating expenses | €86.653207 | €88.487625 | ||
Operating income | -€2.347333 | -€1.724327 | ||
Income from continuing operations | ||||
Net other income | -€0.373912 | -€0.142809 | ||
EBIT | -€2.347333 | -€1.724327 | ||
Interest expense | -€0.008912 | -€0.005835 | ||
Income before tax | -€2.721245 | -€1.867136 | ||
Income tax expense | -€0.050655 | -€0.039573 | ||
Minority interest | ||||
Net income from continuing ops | -€2.67059 | -€1.827563 | ||
Non-recurring events | ||||
Discontinued operations | ||||
Extraordinary items | ||||
Effect of accounting change | ||||
Other items | ||||
Net income | ||||
Net income | -€2.67059 | -€1.827563 | ||
Income (for common shares) | -€2.67059 | -€1.827563 |
Cash flows
(in millions EUR) | 30 Dec 2019 | 29 Sep 2019 | |||
---|---|---|---|---|---|
Net income | €1.191254 | €1.191254 | |||
Operating activities | |||||
Depreciation | |||||
Net income adjustments | |||||
Change in accounts receivable | |||||
Changes in liabilities | |||||
Changes in inventory | |||||
Changes in other operating activities | |||||
Total cash flows from operations | |||||
Investing activities | |||||
Capital expenditures | |||||
Investments | |||||
Other cash flows from investing | |||||
Total cash flows from investing | |||||
Financing activities | |||||
Dividends paid | |||||
Sale and purchase of stock | |||||
Net borrowings | |||||
Other cash flows from financing | |||||
Total cash flows from financing | |||||
Effect of exchange rate | |||||
Change in cash and equivalents |
(in millions EUR) | 2019 | 2018 | ||
---|---|---|---|---|
Net income | -€2.67059 | -€1.827563 | ||
Operating activities | ||||
Depreciation | €1.600999 | |||
Net income adjustments | €0.030566 | |||
Change in accounts receivable | -€0.551 | |||
Changes in liabilities | ||||
Changes in inventory | ||||
Changes in other operating activities | €0.653 | |||
Total cash flows from operations | -€0.094 | |||
Investing activities | ||||
Capital expenditures | -€0.062 | |||
Investments | -€0.5 | |||
Other cash flows from investing | ||||
Total cash flows from investing | -€1.49 | |||
Financing activities | ||||
Dividends paid | ||||
Sale and purchase of stock | ||||
Net borrowings | ||||
Other cash flows from financing | -€0.006 | |||
Total cash flows from financing | €0.975 | |||
Effect of exchange rate | €0.02 | |||
Change in cash and equivalents | -€0.589 |
ZSOL
Balance sheet
(in millions EUR) | |
---|---|
Current assets | |
Cash | |
Short term investments | |
Net receivables | |
Inventory | |
Other current assets | |
Total current assets | |
Long term investments | |
Property, plant & equipment | |
Goodwill | |
Intangible assets | |
Other assets | |
Deferred long term asset charges | |
Total assets | |
Current liabilities | |
Accounts payable | |
Short long term debt | |
Other current liabilities | |
Total current liabilities | |
Long term debt | |
Other liabilities | |
Deferred long term liabilities | |
Minority interest | |
Total liabilities | |
Stockholders' equity | |
Stock option warrants | |
Common stock | |
Retained earnings | |
Treasury stock | |
Capital surplus | |
Other stockholder equity | |
Total stockholder equity | |
Net tangible assets |
(in millions EUR) | 2022 | |
---|---|---|
Current assets | ||
Cash | ||
Short term investments | ||
Net receivables | ||
Inventory | ||
Other current assets | ||
Total current assets | ||
Long term investments | ||
Property, plant & equipment | ||
Goodwill | ||
Intangible assets | ||
Other assets | ||
Deferred long term asset charges | ||
Total assets | ||
Current liabilities | ||
Accounts payable | ||
Short long term debt | ||
Other current liabilities | €0.215 | |
Total current liabilities | €0.735 | |
Long term debt | €1.95 | |
Other liabilities | €0.235 | |
Deferred long term liabilities | ||
Minority interest | ||
Total liabilities | €4.87 | |
Stockholders' equity | ||
Stock option warrants | ||
Common stock | ||
Retained earnings | ||
Treasury stock | ||
Capital surplus | ||
Other stockholder equity | ||
Total stockholder equity | ||
Net tangible assets |
Income statement
(in millions EUR) | |
---|---|
Revenue | |
Total revenue | |
Cost of revenue | |
Gross profit | |
Operating activities | |
Research & development | |
Selling, general & administrative | |
Non-recurring | |
Other operating expenses | |
Total operating expenses | |
Operating income | |
Income from continuing operations | |
Net other income | |
EBIT | |
Interest expense | |
Income before tax | |
Income tax expense | |
Minority interest | |
Net income from continuing ops | |
Non-recurring events | |
Discontinued operations | |
Extraordinary items | |
Effect of accounting change | |
Other items | |
Net income | |
Net income | |
Income (for common shares) |
(in millions EUR) | 2020 | 2019 | ||
---|---|---|---|---|
Revenue | ||||
Total revenue | €1.95 | €1.23 | ||
Cost of revenue | €1.26 | €0.52 | ||
Gross profit | €0.69 | €0.71 | ||
Operating activities | ||||
Research & development | ||||
Selling, general & administrative | €2.91 | €2.98 | ||
Non-recurring | ||||
Other operating expenses | €0.37 | €0.42 | ||
Total operating expenses | €4.82 | €4.19 | ||
Operating income | -€2.87 | -€2.97 | ||
Income from continuing operations | ||||
Net other income | €0.37 | €0.42 | ||
EBIT | ||||
Interest expense | ||||
Income before tax | -€3.03 | -€3.13 | ||
Income tax expense | -€0.04 | -€0.04 | ||
Minority interest | ||||
Net income from continuing ops | ||||
Non-recurring events | ||||
Discontinued operations | ||||
Extraordinary items | ||||
Effect of accounting change | ||||
Other items | -€0.15 | -€0.16 | ||
Net income | ||||
Net income | -€2.99 | -€3.1 | ||
Income (for common shares) | -€2.99 | -€3.1 |
Cash flows
(in millions EUR) | |
---|---|
Net income | |
Operating activities | |
Depreciation | |
Net income adjustments | |
Change in accounts receivable | |
Changes in liabilities | |
Changes in inventory | |
Changes in other operating activities | |
Total cash flows from operations | |
Investing activities | |
Capital expenditures | |
Investments | |
Other cash flows from investing | |
Total cash flows from investing | |
Financing activities | |
Dividends paid | |
Sale and purchase of stock | |
Net borrowings | |
Other cash flows from financing | |
Total cash flows from financing | |
Effect of exchange rate | |
Change in cash and equivalents |
(in millions EUR) | 2020 | 2019 | ||
---|---|---|---|---|
Net income | -€2.99 | -€3.1 | ||
Operating activities | ||||
Depreciation | €0.27 | €0.27 | ||
Net income adjustments | ||||
Change in accounts receivable | ||||
Changes in liabilities | ||||
Changes in inventory | ||||
Changes in other operating activities | ||||
Total cash flows from operations | -€2.3 | -€2.87 | ||
Investing activities | ||||
Capital expenditures | -€0.01 | -€0.05 | ||
Investments | ||||
Other cash flows from investing | ||||
Total cash flows from investing | -€0.01 | -€0.05 | ||
Financing activities | ||||
Dividends paid | ||||
Sale and purchase of stock | ||||
Net borrowings | €0.71 | €0.7 | ||
Other cash flows from financing | €1.19 | €2.04 | ||
Total cash flows from financing | €1.91 | €2.74 | ||
Effect of exchange rate | ||||
Change in cash and equivalents | -€0.4 | -€0.19 |
Profit margin
Debt to assets
Cash flow
Balance sheet
(in millions EUR) | 29 Jun 2022 | 30 Mar 2022 | |||
---|---|---|---|---|---|
Current assets | |||||
Cash | €0.446654 | €0.446654 | |||
Short term investments | |||||
Net receivables | €0.112074 | €0.112074 | |||
Inventory | |||||
Other current assets | €0.058239 | €0.058239 | |||
Total current assets | €0.616967 | €0.616967 | |||
Long term investments | |||||
Property, plant & equipment | €0.022243 | €0.022243 | |||
Goodwill | |||||
Intangible assets | €0.007877 | €0.007877 | |||
Other assets | €0.00886 | €0.00886 | |||
Deferred long term asset charges | |||||
Total assets | €0.655947 | €0.655947 | |||
Current liabilities | |||||
Accounts payable | €0.092468 | €0.092468 | |||
Short long term debt | |||||
Other current liabilities | €0.320191 | €0.320191 | |||
Total current liabilities | €0.412659 | €0.412659 | |||
Long term debt | |||||
Other liabilities | €0.064695 | €0.064695 | |||
Deferred long term liabilities | |||||
Minority interest | |||||
Total liabilities | €0.477354 | €0.477354 | |||
Stockholders' equity | |||||
Stock option warrants | |||||
Common stock | €2.602122 | €2.602122 | |||
Retained earnings | -€7.428739 | -€7.428739 | |||
Treasury stock | €5.005213 | €5.005213 | |||
Capital surplus | |||||
Other stockholder equity | €5.005213 | €5.005213 | |||
Total stockholder equity | €0.178596 | €0.178596 | |||
Net tangible assets | €0.170719 | €0.170719 |
(in millions EUR) | 2021 | 2020 | ||
---|---|---|---|---|
Current assets | ||||
Cash | €0.274301 | €0.31124 | ||
Short term investments | ||||
Net receivables | €0.190288 | €0.150628 | ||
Inventory | ||||
Other current assets | €0.023383 | €0.528936 | ||
Total current assets | €0.487972 | €0.990804 | ||
Long term investments | ||||
Property, plant & equipment | €0.023024 | €0.136816 | ||
Goodwill | ||||
Intangible assets | €0.006396 | €0.04326 | ||
Other assets | €0.072052 | €0.241432 | ||
Deferred long term asset charges | ||||
Total assets | €0.589444 | €1.412312 | ||
Current liabilities | ||||
Accounts payable | €0.20548 | €0.253924 | ||
Short long term debt | ||||
Other current liabilities | €0.300131 | €1.005838 | ||
Total current liabilities | €0.514446 | €1.286315 | ||
Long term debt | ||||
Other liabilities | €0.075 | €0.126 | ||
Deferred long term liabilities | ||||
Minority interest | ||||
Total liabilities | €0.589446 | €1.412315 | ||
Stockholders' equity | ||||
Stock option warrants | ||||
Common stock | €2.602122 | €13.010612 | ||
Retained earnings | -€7.607335 | -€18.015824 | ||
Treasury stock | €5.005213 | €5.005211 | ||
Capital surplus | ||||
Other stockholder equity | €5.005213 | €5.005211 | ||
Total stockholder equity | -€0.000001 | |||
Net tangible assets | -€0.006396 | -€0.043261 |
Income statement
(in millions EUR) | 29 Jun 2022 | 30 Mar 2022 | |||
---|---|---|---|---|---|
Revenue | |||||
Total revenue | €0.460043 | €0.460043 | |||
Cost of revenue | €0.120824 | €0.120824 | |||
Gross profit | €0.339219 | €0.339219 | |||
Operating activities | |||||
Research & development | |||||
Selling, general & administrative | |||||
Non-recurring | |||||
Other operating expenses | €0.212917 | €0.212917 | |||
Total operating expenses | €0.336456 | €0.336456 | |||
Operating income | €0.123588 | €0.123588 | |||
Income from continuing operations | |||||
Net other income | |||||
EBIT | €0.123588 | €0.123588 | |||
Interest expense | |||||
Income before tax | €0.123588 | €0.123588 | |||
Income tax expense | €0.000102 | €0.000102 | |||
Minority interest | |||||
Net income from continuing ops | €0.123486 | €0.123486 | |||
Non-recurring events | |||||
Discontinued operations | |||||
Extraordinary items | |||||
Effect of accounting change | |||||
Other items | |||||
Net income | |||||
Net income | €0.123486 | €0.123486 | |||
Income (for common shares) | €0.123486 | €0.123486 |
(in millions EUR) | 2021 | 2020 | ||
---|---|---|---|---|
Revenue | ||||
Total revenue | €1.910861 | €1.642482 | ||
Cost of revenue | €0.435541 | €0.575901 | ||
Gross profit | €1.47532 | €1.066581 | ||
Operating activities | ||||
Research & development | ||||
Selling, general & administrative | ||||
Non-recurring | ||||
Other operating expenses | -€0.012987 | €1.257677 | ||
Total operating expenses | €0.441101 | €3.208438 | ||
Operating income | €1.46976 | -€1.565956 | ||
Income from continuing operations | ||||
Net other income | -€1.291828 | -€0.130525 | ||
EBIT | €1.46976 | -€1.565956 | ||
Interest expense | -€0.003296 | -€0.005346 | ||
Income before tax | €0.177932 | -€1.696481 | ||
Income tax expense | €0.008428 | €0.000629 | ||
Minority interest | ||||
Net income from continuing ops | €0.169504 | -€1.69711 | ||
Non-recurring events | ||||
Discontinued operations | ||||
Extraordinary items | ||||
Effect of accounting change | ||||
Other items | ||||
Net income | ||||
Net income | €0.169504 | -€1.69711 | ||
Income (for common shares) | €0.169504 | -€1.69711 |
Cash flows
(in millions EUR) | 29 Jun 2022 | 30 Mar 2022 | |||
---|---|---|---|---|---|
Net income | €0.123486 | €0.123486 | |||
Operating activities | |||||
Depreciation | €0.002715 | €0.002715 | |||
Net income adjustments | |||||
Change in accounts receivable | |||||
Changes in liabilities | -€0.050894 | -€0.050894 | |||
Changes in inventory | €0.019089 | €0.019089 | |||
Changes in other operating activities | -€0.005153 | -€0.005153 | |||
Total cash flows from operations | €0.089242 | €0.089242 | |||
Investing activities | |||||
Capital expenditures | -€0.001623 | -€0.001623 | |||
Investments | |||||
Other cash flows from investing | |||||
Total cash flows from investing | -€0.003066 | -€0.003066 | |||
Financing activities | |||||
Dividends paid | |||||
Sale and purchase of stock | |||||
Net borrowings | |||||
Other cash flows from financing | |||||
Total cash flows from financing | |||||
Effect of exchange rate | |||||
Change in cash and equivalents | €0.086177 | €0.086177 |
(in millions EUR) | 2021 | 2020 | ||
---|---|---|---|---|
Net income | €0.169504 | -€1.69711 | ||
Operating activities | ||||
Depreciation | €0.018547 | €1.50416 | ||
Net income adjustments | €0.138331 | €0.092943 | ||
Change in accounts receivable | ||||
Changes in liabilities | -€0.771868 | €0.18152 | ||
Changes in inventory | €0.465772 | -€0.248606 | ||
Changes in other operating activities | -€0.051 | €0.0085 | ||
Total cash flows from operations | -€0.030717 | -€0.158593 | ||
Investing activities | ||||
Capital expenditures | -€0.012024 | |||
Investments | -€0.006223 | -€0.006223 | ||
Other cash flows from investing | ||||
Total cash flows from investing | -€0.006223 | -€0.003014 | ||
Financing activities | ||||
Dividends paid | ||||
Sale and purchase of stock | ||||
Net borrowings | ||||
Other cash flows from financing | ||||
Total cash flows from financing | €0.2 | |||
Effect of exchange rate | ||||
Change in cash and equivalents | -€0.036938 | €0.038392 |
Profit margin
Debt to assets
Cash flow
Balance sheet
(in millions USD) | 30 Mar 2021 | |
---|---|---|
Current assets | ||
Cash | $2.18564 | |
Short term investments | ||
Net receivables | ||
Inventory | ||
Total current assets | $4.206929 | |
Long term investments | ||
Property, plant & equipment | ||
Goodwill & intangible assets | ||
Total noncurrent assets | ||
Total investments | ||
Total assets | $1,004.218419 | |
Current liabilities | ||
Accounts payable | $1.755179 | |
Deferred revenue | ||
Short long term debt | ||
Total current liabilities | $3.059286 | |
Long term debt | ||
Total noncurrent liabilities | ||
Total debt | ||
Total liabilities | $999.218416 | |
Stockholders' equity | ||
Retained earnings | -$3.336439 | |
Other stockholder equity | ||
Total stockholder equity | $5.000003 |
(in millions USD) | 2020 | |
---|---|---|
Current assets | ||
Cash | ||
Short term investments | ||
Net receivables | ||
Inventory | ||
Total current assets | ||
Long term investments | ||
Property, plant & equipment | ||
Goodwill & intangible assets | ||
Total noncurrent assets | ||
Total investments | ||
Total assets | $1.165929 | |
Current liabilities | ||
Accounts payable | $0.052324 | |
Deferred revenue | ||
Short long term debt | ||
Total current liabilities | $1.166137 | |
Long term debt | ||
Total noncurrent liabilities | ||
Total debt | ||
Total liabilities | $1.166137 | |
Stockholders' equity | ||
Retained earnings | -$0.025208 | |
Other stockholder equity | ||
Total stockholder equity | -$0.000208 |
Income statement
(in millions USD) | 30 Mar 2021 | |
---|---|---|
Revenue | ||
Total revenue | ||
Cost of revenue | ||
Gross profit | ||
Operating activities | ||
Research & development | ||
Selling, general & administrative | $3.322721 | |
Total operating expenses | $3.322721 | |
Operating income | -$3.322721 | |
Income from continuing operations | ||
EBIT | -$3.322721 | |
Income tax expense | ||
Interest expense | ||
Net income | ||
Net income | -$3.311231 | |
Income (for common shares) | -$3.311231 |
(in millions USD) | 2020 | |
---|---|---|
Revenue | ||
Total revenue | ||
Cost of revenue | ||
Gross profit | ||
Operating activities | ||
Research & development | ||
Selling, general & administrative | $0.151248 | |
Total operating expenses | $0.151248 | |
Operating income | -$0.151248 | |
Income from continuing operations | ||
EBIT | -$0.151248 | |
Income tax expense | ||
Interest expense | ||
Net income | ||
Net income | -$0.151248 | |
Income (for common shares) | -$0.151248 |
Cash flows
(in millions USD) | 30 Mar 2021 | |
---|---|---|
Net income | -$3.311231 | |
Operating activities | ||
Depreciation | ||
Business acquisitions & disposals | ||
Stock-based compensation | ||
Total cash flows from operations | -$3.249942 | |
Investing activities | ||
Capital expenditures | ||
Investments | ||
Total cash flows from investing | -$1,000 | |
Financing activities | ||
Dividends paid | ||
Sale and purchase of stock | ||
Net borrowings | -$0.285919 | |
Total cash flows from financing | $1,005.435582 | |
Effect of exchange rate | ||
Change in cash and equivalents | $2.18564 |
(in millions USD) | 2020 | |
---|---|---|
Net income | -$0.151248 | |
Operating activities | ||
Depreciation | ||
Business acquisitions & disposals | ||
Stock-based compensation | ||
Total cash flows from operations | ||
Investing activities | ||
Capital expenditures | ||
Investments | ||
Total cash flows from investing | ||
Financing activities | ||
Dividends paid | ||
Sale and purchase of stock | ||
Net borrowings | ||
Total cash flows from financing | ||
Effect of exchange rate | ||
Change in cash and equivalents |
SCHYY
Profit margin
Debt to assets
Cash flow
Balance sheet
(in millions USD) | 30 Jun 2024 | 31 Mar 2024 | |||
---|---|---|---|---|---|
Current assets | |||||
Cash | $1,787 | $1,787 | |||
Short term investments | |||||
Net receivables | $233 | $233 | |||
Inventory | $26 | $26 | |||
Other current assets | |||||
Total current assets | $2,046 | $2,046 | |||
Long term investments | |||||
Property, plant & equipment | $7,324 | $7,324 | |||
Goodwill | |||||
Intangible assets | $453 | $453 | |||
Other assets | $732 | $732 | |||
Deferred long term asset charges | |||||
Total assets | $10,555 | $10,555 | |||
Current liabilities | |||||
Accounts payable | $1,191 | $1,191 | |||
Short long term debt | $17 | $17 | |||
Other current liabilities | $109 | $109 | |||
Total current liabilities | $1,317 | $1,317 | |||
Long term debt | $8,136 | $8,136 | |||
Other liabilities | -$520 | $541 | |||
Deferred long term liabilities | |||||
Minority interest | |||||
Total liabilities | $10,028 | $10,028 | |||
Stockholders' equity | |||||
Stock option warrants | |||||
Common stock | $81 | $81 | |||
Retained earnings | |||||
Treasury stock | |||||
Capital surplus | |||||
Other stockholder equity | $446 | $446 | |||
Total stockholder equity | $527 | $527 | |||
Net tangible assets |
(in millions USD) | 2023 | 2022 | ||
---|---|---|---|---|
Current assets | ||||
Cash | $1,361 | $790 | ||
Short term investments | ||||
Net receivables | $296 | $93 | ||
Inventory | $26 | $19 | ||
Other current assets | $14 | $925 | ||
Total current assets | $1,683 | $1,867 | ||
Long term investments | ||||
Property, plant & equipment | $7,377 | $7,944 | ||
Goodwill | ||||
Intangible assets | $476 | $31 | ||
Other assets | $760 | $701 | ||
Deferred long term asset charges | ||||
Total assets | $10,258 | $10,562 | ||
Current liabilities | ||||
Accounts payable | $1,181 | $834 | ||
Short long term debt | $16 | $1,963 | ||
Other current liabilities | $175 | $74 | ||
Total current liabilities | $1,372 | $2,871 | ||
Long term debt | $8,312 | $8,218 | ||
Other liabilities | -$520 | -$872 | ||
Deferred long term liabilities | ||||
Minority interest | ||||
Total liabilities | $10,262 | $11,262 | ||
Stockholders' equity | ||||
Stock option warrants | ||||
Common stock | $81 | $81 | ||
Retained earnings | -$1,766 | -$2,463 | ||
Treasury stock | ||||
Capital surplus | ||||
Other stockholder equity | $78 | $80 | ||
Total stockholder equity | -$4 | -$700 | ||
Net tangible assets |
Income statement
(in millions USD) | 30 Jun 2024 | 31 Mar 2024 | |||
---|---|---|---|---|---|
Revenue | |||||
Total revenue | $1,775.5 | $1,775.5 | |||
Cost of revenue | $323.5 | $323.5 | |||
Gross profit | $1,452 | $1,452 | |||
Operating activities | |||||
Research & development | |||||
Selling, general & administrative | |||||
Non-recurring | |||||
Other operating expenses | $1,026.5 | $1,026.5 | |||
Total operating expenses | $1,431.5 | $1,431.5 | |||
Operating income | $344 | $344 | |||
Income from continuing operations | |||||
Net other income | $1,026.5 | $1,026.5 | |||
EBIT | |||||
Interest expense | -$110 | -$110 | |||
Income before tax | $249 | $249 | |||
Income tax expense | -$21.5 | -$21.5 | |||
Minority interest | |||||
Net income from continuing ops | |||||
Non-recurring events | |||||
Discontinued operations | |||||
Extraordinary items | |||||
Effect of accounting change | |||||
Other items | $95 | $95 | |||
Net income | |||||
Net income | $270.5 | $270.5 | |||
Income (for common shares) | $270.5 | $270.5 |
(in millions USD) | 2023 | 2022 | ||
---|---|---|---|---|
Revenue | ||||
Total revenue | $6,534 | $1,605 | ||
Cost of revenue | $1,298 | $1,118 | ||
Gross profit | $5,236 | $487 | ||
Operating activities | ||||
Research & development | ||||
Selling, general & administrative | $76 | $26 | ||
Non-recurring | ||||
Other operating expenses | $3,624 | $2,058 | ||
Total operating expenses | $5,284 | $2,770 | ||
Operating income | $1,250 | -$1,165 | ||
Income from continuing operations | ||||
Net other income | $3,624 | $2,058 | ||
EBIT | ||||
Interest expense | -$523 | -$435 | ||
Income before tax | $741 | -$1,588 | ||
Income tax expense | $49 | -$6 | ||
Minority interest | ||||
Net income from continuing ops | ||||
Non-recurring events | ||||
Discontinued operations | ||||
Extraordinary items | ||||
Effect of accounting change | ||||
Other items | $521 | $425 | ||
Net income | ||||
Net income | $692 | -$1,582 | ||
Income (for common shares) | $692 | -$1,582 |
Cash flows
(in millions USD) | 30 Jun 2024 | 31 Mar 2024 | |||
---|---|---|---|---|---|
Net income | $270.5 | $270.5 | |||
Operating activities | |||||
Depreciation | $191.5 | $191.5 | |||
Net income adjustments | |||||
Change in accounts receivable | |||||
Changes in liabilities | |||||
Changes in inventory | |||||
Changes in other operating activities | |||||
Total cash flows from operations | $518.5 | $518.5 | |||
Investing activities | |||||
Capital expenditures | -$109 | -$109 | |||
Investments | |||||
Other cash flows from investing | $13 | $13 | |||
Total cash flows from investing | -$96 | -$96 | |||
Financing activities | |||||
Dividends paid | |||||
Sale and purchase of stock | |||||
Net borrowings | -$87 | -$87 | |||
Other cash flows from financing | -$122.5 | -$122.5 | |||
Total cash flows from financing | -$209.5 | -$209.5 | |||
Effect of exchange rate | |||||
Change in cash and equivalents | $213 | $213 |
(in millions USD) | 2023 | 2022 | ||
---|---|---|---|---|
Net income | $692 | -$1,582 | ||
Operating activities | ||||
Depreciation | $809 | $727 | ||
Net income adjustments | ||||
Change in accounts receivable | ||||
Changes in liabilities | ||||
Changes in inventory | ||||
Changes in other operating activities | ||||
Total cash flows from operations | $2,293 | -$473 | ||
Investing activities | ||||
Capital expenditures | -$231 | -$203 | ||
Investments | ||||
Other cash flows from investing | $51 | -$122 | ||
Total cash flows from investing | -$180 | -$325 | ||
Financing activities | ||||
Dividends paid | ||||
Sale and purchase of stock | ||||
Net borrowings | -$1,950 | $2,190 | ||
Other cash flows from financing | -$502 | -$369 | ||
Total cash flows from financing | -$2,452 | $1,821 | ||
Effect of exchange rate | -$13 | $4 | ||
Change in cash and equivalents | -$341 | $1,024 |